A Non-invasive Index of Microciculatory Resistance
A Clinical Trial for CT Myocardial Perfusion Based Non-invasive Index of Microciculatory Resistance
1 other identifier
interventional
295
1 country
1
Brief Summary
Coronary artery microvascular disease (CMVD) lacks reliable and non-invasive quantitative diagnosis methods. Improving coronary microcirculation has become one of the main goals of coronary heart disease treatment. In this study, by establishing the key influencing factors of myocardial microcirculation perfusion, an accurate three-dimensional reconstruction method of coronary artery was established, and a non-invasive coronary microcirculation resistance index (CT-IMR) calculation method based on computational fluid method mechanics was established. At the same time, a phase I single-center clinical verification and a multi-center clinical verification of the non-invasive coronary microcirculation function precision assessment system were carried out, and a non-invasive coronary microcirculation detection system and technology were established.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2020
CompletedFirst Posted
Study publicly available on registry
September 18, 2020
CompletedStudy Start
First participant enrolled
December 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJune 4, 2025
June 1, 2025
2 years
September 8, 2020
June 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
sensitivity and specificity
The sensitivity and specificity of CT-IMR in the diagnosis of microcirculation dysfunction were studied.
up to 12 months
Secondary Outcomes (1)
diagnostic
up to 12 months
Study Arms (1)
Study group
EXPERIMENTALAll consecutive patients undergoing outine CT angiography and dynamic CT-myocardial perfusion imaging(MPI) will be potentially eligible for inclusion in the trial. Assessment of coronary stenosis severity using invasive fractional flow reserve (FFR) and the status of myocardial microcirculation perfusion including coronary flow reserve (CFR) and index of microvascular resistance (IMR) will be performed as part of invasive coronary angiography(CAG).
Interventions
The patients who enrolled the study will undergo coronary CT angiography(CCTA), dynamic CT-MPI, invasive coronary angiography and invasive computation of fractional flow reserve (FFR)
Eligibility Criteria
You may qualify if:
- Subject must be older than 18 years
- Written informed consent available
- Subject is indicated for invasive coronary angiography
- Subject need to be taken within 30 days after enrolment
You may not qualify if:
- Previous PCI or CABG
- Subject is not eligible for measuring IMR
- Complicated complex congenital heart disease
- Artificial pacemaker or internal defibrillator leads implanted
- Implanted artificial heart valve
- Severe arrhythmia including complete AV block, ventricular arrhythmia
- Impaired chronic renal function (serum creatinine\>1.5ULN)
- Allergic to iodine
- Pregnancy
- Body mass index \>35 kg/m2
- Left ventricle is markedly thickened
- Needs for emergency procedures
- Severe distortion of in the blood vessel
- Unstable haemodynamics including abrupt chest pain cardiogenic shock, unstable blood pressure (systolic \< 90mmHg), severe congestive heart failure or pulmonary edema
- Life-threatening diseases (life expectancy \< 2 months)
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First People's Hospital of Hangzhou
Hanzhou, Zhejiang, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
September 8, 2020
First Posted
September 18, 2020
Study Start
December 15, 2022
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
June 4, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- When will data be available (start and end dates)?Beginning 3 months. No end data.
- Access Criteria
- Proposals should be directed to zdsyhjy0902@zju.edu.cn. To gain access, data requestors will need to sign a data access agreement.
Individual participant data that underlie the results reported in this article after deidentification (text, table, figures, and appendices).